Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Apparatus and method for multiplying frequency of a clock signal
Semiconductor device having a bonding pad and shield structure of different thickness
System of providing an internet web site that assists medical professionals draft a letter of medical necessity or other documentation for transmission to a third party payer on behalf of a pa
Wafer level packaging structure with large contact area and preparation method thereof
Wearable display device
Engineered magnetic layer with improved perpendicular anisotropy using glassing agents for spintronic applications
  Randomly Featured Patents
Composite label web
Fish lure
Measuring blood pressure in noisy environments
Decryption of retransmitted data in an encrypted communication system
Aerial seeder and method
Automatic programming method and automatic programming device
In-shower and bath compositions
Human macrophage metalloelastase
Fuel cutoff valve
Portable electronic device and movement sensor thereof